Celebrating 30 years in dermatology research, Shiseido Company, Ltd., announced it will extend collaborations with dermatological laboratory Cutaneous Biology Research Center (CBRC), effective July 2021 through June 2027.
CBRC was founded in 1989 and is known as a world-class laboratory in the field of dermatology. The center was established by Harvard Medical School Dermatology Research Labs and Massachusetts General Hospital (MGH) in Boston, MA, USA.
Shiseido has collaborated for 30 years with the firm, pioneering open innovation and pursuing unprecedented research collaborations with external organizations both nationally and internationally. Much of this cutting-edge research is utilized in its product research and development.
Moving forward, to achieve its corporate mission, "Beauty Innovations for a Better World," Shiseido will continue research with CBRC in areas including UV rays and aging, as well as the development of innovative cosmetic products. Furthermore, the company will provide consumers with information to maintain healthy skin through seminars and symposiums.
'We have delivered many outstanding research
achievements, more than we had initially imagined,
realizing ideal collaboration between laboratories in
academia and a company.'
"In our quest to remain vital for the next 100 years and beyond, this year, we at Shiseido created a new corporate mission 'Beauty Innovations for a Better World,'" said President and CEO Masahiko Uotani, of Shiseido. "Ongoing efforts to foster innovation is our responsibility and mission to make this world better through the power of beauty. The CBRC is an indispensable and important partner for Shiseido to create unprecedented, first-of-its-kind value and change the lives of people around the world. Let us cling together for the future and challenge for the innovation that surpasses society's expectations."
Executive Vice President Yoichi Shimatani, of Shiseido, added "It has been 30 years since we began our partnership with the CBRC. We have delivered many outstanding research achievements, more than we had initially imagined, realizing ideal collaboration between laboratories in academia and a company. We will continue to create innovation with the CBRC, a state-of-the-art laboratory that symbolizes our open innovation activities."
CBRC Director David E. Fisher remarked, "The Shiseido-CBRC relationship is a source of immense pride to dermatology at Mass General Hospital/Harvard Medical School. Close collaboration at the cutting edge of science is the shared mission, and numerous significant discoveries continue to be made through common efforts. We are proud to celebrate 30 years of important discoveries by our scientists working together, and look forward to continued progress in optimizing all aspects of skin health and well-being."
